DexCom announced on February 12, 2026 that its over‑the‑counter continuous glucose monitoring system, Stelo, will receive a suite of AI‑enabled features. The update adds a comprehensive nutrition database, expanded meal‑tracking capabilities, and personalized behavioral insights that link real‑time glucose data to structured dietary information.
The new functionality builds on the AI‑powered meal‑logging feature that DexCom introduced in its Q3 2025 earnings release. By automatically matching logged foods to a curated database, the system can generate individualized recommendations and highlight patterns that influence glucose excursions, giving users a clearer picture of how specific foods affect their metabolic health.
Stelo has been positioned by DexCom as a device for people with prediabetes or type 2 diabetes who are not on insulin, and for consumers interested in general wellness tracking. The AI enhancements are intended to broaden the product’s appeal beyond traditional diabetes care and to support a larger share of the estimated $50 billion wellness market.
The announcement was made during DexCom’s Q4 2025 earnings presentation, which reported preliminary revenue of $1.260 billion and a 13 % year‑over‑year increase. The company’s guidance for 2026 projects total revenue of $5.16 billion to $5.25 billion, reflecting confidence that the expanded Stelo offering will drive sensor sales and subscription uptake.
Management emphasized that the AI features are part of DexCom’s broader strategy to transition from a premium medical‑device company to a direct‑to‑consumer metabolic‑health platform. The company highlighted that the Stelo rollout, combined with the new AI tools, is expected to accelerate user engagement and create recurring revenue streams beyond sensor sales.
The content on EveryTicker is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.